The place of pemetrexed in the management of non-small-cell lung cancer patients

Author： Tomasini Pascale   Greillier Laurent   Khobta Nataliya   Barlesi Fabrice  

Publisher： Informa Healthcare

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.3, 2013-03, pp. : 257-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa   Ge Wei   Zhang Ling   Zhao Zhenyu   Jie Fangfang  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature

By Tartarone Alfredo  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1937-1940

Future Medicine

Access to resources Recommend Favorite

Role of Pemetrexed in Non-Small Cell Lung Cancer

By Longo-Sorbello Giuseppe   Chen Bobin   Budak-Alpdogan Tulin   Bertino Joseph  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in Malignant Pleural Mesothelioma and Non-Small-Cell Lung Cancer

By Dean M. Robinson   Gillian M. Keating   Antona J. Wagstaff  

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 387-399

Adis International

Access to resources Recommend Favorite

The landscape of EGFR pathways and personalized management of non-small-cell lung cancer

By Cheng Liang   Zhang Shaobo   Alexander Riley   Yao Yongxue   MacLennan Gregory T   Pan Chong-xian   Huang Jiaoti   Wang Mingsheng   Montironi Rodolfo   Lopez-Beltran Antonio  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 519-541

Future Medicine

Access to resources Recommend Favorite